Home > News > Cell Genesys: The Promise of GVAX
May 7th, 2007
Cell Genesys: The Promise of GVAX
Abstract:
In recent years, there have been some great improvements in the field of cancer therapy thanks to early diagnosis and new forms of therapies, such as monoclonal antibodies and nanoparticle-coated compounds. For over two decades, cancer vaccines have demonstrated impressive results in early pre-clinical trials, which gave rise to great expectations within the scientific community. Unfortunately, scientists couldn't replicate the early phase success into clinical trials, but there are finally some encouraging signs . With several promising candidates which are currently being evaluated in clinical trials, the cancer vaccine field might become the next big thing in cancer therapy.
Source:
biotech.seekingalpha.com
Bookmark:
| Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||